{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:41:09Z","timestamp":1793407269484,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejpb.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T21:04:00Z","timestamp":1529010240000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery"],"prefix":"10.1016","volume":"129","author":[{"given":"Laurent","family":"Salade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-5790","authenticated-orcid":false,"given":"Nathalie","family":"Wauthoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Amighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Goole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.06.011_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.peptides.2012.05.006","article-title":"The antimicrobial activity of the appetite peptide hormone ghrelin","volume":"36","author":"Min","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2018.06.011_b0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.nut.2008.06.013","article-title":"Emergence of ghrelin as a treatment for cachexia syndromes","volume":"24","author":"DeBoer","year":"2008","journal-title":"Nutrition"},{"issue":"2013","key":"10.1016\/j.ejpb.2018.06.011_b0015","article-title":"Structure and physiological actions of ghrelin","volume":"25","author":"Delporte","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.ejpb.2018.06.011_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/en.2005-0973","article-title":"Effects of a Fixed Meal Pattern on Ghrelin Secretion: evidence for a Learned Response Independent of Nutrient Status","volume":"147","author":"Drazen","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejpb.2018.06.011_b0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ejpb.2018.06.011_b0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejpb.2018.06.011_b0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0040","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2018.06.011_b0045","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.2147\/IJN.S147650","article-title":"Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia","volume":"12","author":"Salade","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2018.06.011_b0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.06.011_b0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.antiviral.2011.09.012","article-title":"Brain distribution of ribavirin after intranasal administration","volume":"92","author":"Colombo","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0060","doi-asserted-by":"crossref","first-page":"e0159150","DOI":"10.1371\/journal.pone.0159150","article-title":"Nasal absorption of macromolecules from powder formulations and effects of sodium carboxymethyl cellulose on their absorption","volume":"11","author":"Tanaka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.06.011_b0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0928-0987(01)00094-X","article-title":"Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin","volume":"13","author":"Morimoto","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0070","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1023\/A:1019881706159","article-title":"Insoluble powder formulation as an effective nasal drug delivery system","volume":"19","author":"Ishikawa","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0075","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Ilium","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.06.011_b0085","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation","volume":"42","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.011_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-015-0026-9","article-title":"A novel nasal powder formulation of glucagon: toxicology studies in animal models","volume":"16","author":"Reno","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.10.049","article-title":"Influence of deposition and spray pattern of nasal powders on insulin bioavailability","volume":"310","author":"Pringels","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.011_b0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2009.05.041","article-title":"Influence of heat treatment on spray-dried mixtures of Amioca\u00ae starch and Carbopol\u00ae 974P used as carriers for nasal drug delivery","volume":"378","author":"Coucke","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.011_b0105","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S147650","article-title":"Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia","volume":"12","author":"Salade","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejpb.2018.06.011_b0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2018.06.011_b0115","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.2174\/1381612821666150923095958","article-title":"Nose to brain delivery: new trends in amphiphile-based soft nanocarriers","volume":"21","author":"Marianecci","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2018.06.011_b0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.addr.2011.05.003","article-title":"Lactose characteristics and the generation of the aerosol","volume":"64","author":"Pilcer","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2018.06.011_b0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4103\/0250-474X.38470","article-title":"Preparation of mucoadhesive microspheres for nasal delivery by spray drying","volume":"69","author":"Rathananand","year":"2007","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12249-007-9024-6","article-title":"Development of spray dried liposomal dry powder inhaler of Dapsone","volume":"9","author":"Chougule","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.06.011_b0135","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"van Woensel","year":"2013","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.ejpb.2018.06.011_b0140","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jpba.2009.09.040","article-title":"Validation of a method for the quantitation of ghrelin and unacylated ghrelin by HPLC","volume":"51","author":"Staes","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2018.06.011_b0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bst0060607","article-title":"A colorimetric assay for glycoproteins based on the periodic acid\/Schiff stain [proceedings]","volume":"6","author":"Mantle","year":"1978","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejpb.2018.06.011_b0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(98)00027-1","article-title":"In vitro evaluation of the mucoadhesive properties of chitosan microspheres","volume":"166","author":"He","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.011_b0155","article-title":"Pharmaceutical Manufacturing Handbook","volume":"1327\u20131366","author":"Tamilvanan","year":"2008","journal-title":"Pharm. Manuf. Handbook: Prod. Process."},{"key":"10.1016\/j.ejpb.2018.06.011_b0160","unstructured":"D.S. Gardenhire, J.L. Rau, Rau\u2019s respiratory care pharmacology."},{"key":"10.1016\/j.ejpb.2018.06.011_b0165","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1208\/s12249-010-9492-y","article-title":"A statistical approach to optimize the spray drying of starch particles: application to dry powder coating","volume":"11","author":"Bilancetti","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.06.011_b0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2008.11.009","article-title":"Development and testing of particulate formulations for the nasal delivery of antibodies","volume":"135","author":"Kaye","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.06.011_b0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajps.2014.09.004","article-title":"A review on phospholipids and their main applications in drug delivery systems","volume":"10","author":"Li","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfoodeng.2014.09.004","article-title":"Spray drying: an overview on wall deposition, process and modeling","volume":"146","author":"Keshani","year":"2015","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ejpb.2018.06.011_b0185","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1023\/A:1011983322594","article-title":"Effect of spray drying and subsequent processing conditions on residual moisture content and physical\/biochemical stability of protein inhalation powders","volume":"15","author":"Maa","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jps.20484","article-title":"Anthrax vaccine powder formulations for nasal mucosal delivery","volume":"95","author":"Jiang","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(98)00326-3","article-title":"Influence of the moisture on the performance of a new dry powder inhaler","volume":"177","author":"Maggi","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.011_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12249-013-0036-0","article-title":"The effect of moisture on the flowability of pharmaceutical excipients","volume":"15","author":"Crouter","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2018.06.011_b0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.powtec.2008.06.017","article-title":"Flowability of moist pharmaceutical powders","volume":"189","author":"Emery","year":"2009","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0210","unstructured":"Saiful Hassan, M., Wai Man Lau, R. Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties. (2009) 10.1208\/s12249-009-9313-3."},{"key":"10.1016\/j.ejpb.2018.06.011_b0215","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/jps.23955","article-title":"Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles\/nanoparticles for targeted pulmonary delivery as dry powder inhalers","volume":"103","author":"Li","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0220","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/jps.10423","article-title":"Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential","volume":"92","author":"Kockisch","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.snb.2007.01.022","article-title":"Rheological, dielectric and diffusion analysis of mucin\/carbopol matrices used in amperometric biosensors","volume":"124","author":"Capra","year":"2007","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.ejpb.2018.06.011_b0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jps.22742","article-title":"Stable dry powder formulation for nasal delivery of anthrax vaccine","volume":"101","author":"Wang","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0235","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/jps.21972","article-title":"Structural effects caused by spray- and freeze-drying of liposomes and bilayer disks","volume":"99","author":"Wessman","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/10408449109019571","article-title":"Nasal cavity enzymes involved in xenobiotic metabolism: effects on the toxicity of inhalants","volume":"21","author":"Dahl","year":"1991","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)00158-2","article-title":"Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats","volume":"113","author":"Morimoto","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2018.06.011_b0250","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejpb.2018.06.011_b0255","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1023\/A:1011933410898","article-title":"Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump","volume":"16","author":"Suman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/08958370903278077","article-title":"A computational fluid dynamics approach to assess interhuman variability in hydrogen sulfide nasal dosimetry","volume":"22","author":"Schroeter","year":"2010","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0270","unstructured":"N.J. Johnson, L.R. Hanson, W.H. Frey Ii, Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. 10.1021\/mp100029t."},{"key":"10.1016\/j.ejpb.2018.06.011_b0275","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11095-011-0641-0","article-title":"Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles","volume":"29","author":"Liu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0280","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/jamp.2011.0924","article-title":"Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump","volume":"25","author":"Djupesland","year":"2012","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.06.011_b0285","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1211\/jpp.61.09.0012","article-title":"Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device","volume":"61","author":"Luthringer","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0290","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2012-4247","article-title":"Clinical review: the human experience with ghrelin administration","volume":"98","author":"Garin","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejpb.2018.06.011_b0295","doi-asserted-by":"crossref","first-page":"R575","DOI":"10.1152\/ajpregu.00448.2006","article-title":"Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats","volume":"292","author":"Szentirmai","year":"2007","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejpb.2018.06.011_b0300","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11095-013-1157-6","article-title":"Validation of anatomical models to study aerosol deposition in human nasal cavities","volume":"31","author":"Le Guellec","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.06.011_b0305","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0310","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaerosci.2016.01.013","article-title":"Modeling of inertial deposition in scaled models of rat and human nasal airways: Towards in vitro regional dosimetry in small animals","volume":"99","author":"Xi","year":"2016","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ejpb.2018.06.011_b0315","unstructured":"R. Scherlie\u00df, Comparison of in vitro methods to determine nasal versus lung deposition of a protein formulation."},{"key":"10.1016\/j.ejpb.2018.06.011_b0320","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm. Res."}],"updated-by":[{"DOI":"10.1016\/j.ejpb.2018.08.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000}}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111830571X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964111830571X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T14:25:19Z","timestamp":1529677519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964111830571X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":63,"alternative-id":["S093964111830571X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.06.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}